GADD45G and myeloproliferative neoplasm: Together, we show that the reduced expression of GADD45g in MPNs is associated with JAK2V617F mutation and histone deacetylation, and GADD45g reduction partially mediates the pathogenic role of JAK2V617F mutation in MPN cells.